Skip to main content
HANGZHOU AGS MEDTECH CO.,LTD logo

HANGZHOU AGS MEDTECH CO.,LTD — Investor Relations & Filings

Ticker · 688581 ISIN · CNE100005ZF0 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 393 across all filing types
Latest filing 2025-09-10 Board/Management Inform…
Country CN China
Listing Shanghai Stock Exchange 688581

About HANGZHOU AGS MEDTECH CO.,LTD

http://www.bioags.com/en/index.aspx

Hangzhou AGS MedTech Co., Ltd. specializes in the research, development, and manufacturing of minimally invasive medical instruments, primarily focusing on endoscopic accessories. The product portfolio encompasses a comprehensive range of disposable devices for gastrointestinal and respiratory interventions, including biopsy forceps, hemoclips, injection needles, polypectomy snares, and guide wires. The company integrates advanced manufacturing processes with rigorous quality management systems, adhering to international standards such as ISO 13485, CE, and FDA. By providing high-precision diagnostic and therapeutic tools, the organization supports clinical procedures in gastroenterology and pulmonology. Its technical expertise facilitates the delivery of reliable solutions aimed at improving procedural outcomes and patient safety in global healthcare markets.

Recent filings

Filing Released Lang Actions
安杰思第三届董事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at a board of directors meeting of Hangzhou Anjiesi Medical Technology Co., Ltd. It includes information about stock incentive plans, governance changes such as the cancellation of the supervisory board and amendments to the company charter, and the scheduling of a shareholders' meeting. The content focuses on board decisions and governance matters rather than financial results, audit opinions, or regulatory filings. It is not a full annual or interim report, nor is it a simple announcement of a report publication. The document fits the category of Board/Management Information (MANG) because it reports on board meeting resolutions and governance changes.
2025-09-10 Chinese
安杰思第三届监事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the fourth meeting of the third Supervisory Board of Hangzhou Anjiesi Medical Technology Co., Ltd. It details the meeting's attendance, the resolutions passed regarding the 2023 restricted stock incentive plan, adjustments to the plan, cancellation of some granted but unvested restricted stocks, and a proposal to abolish the Supervisory Board and amend the company bylaws. The document references other announcements with specific announcement numbers and URLs for further details, indicating this is a meeting resolution announcement rather than a full report. The content focuses on governance and supervisory board decisions rather than financial results or detailed reports. The document length is 2137 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits best under Board/Management Information (MANG) as it announces decisions related to company governance and supervisory board changes.
2025-09-10 Chinese
安杰思股东会网络投票实施细则
Governance Information Classification · 95% confidence The document is titled as the "Implementation Rules for Online Voting at the Shareholders' Meeting" of Hangzhou Anjiese Medical Technology Co., Ltd. It details procedures, rules, and regulations for conducting online voting during shareholders' meetings, including voting platforms, eligibility, vote counting, and disclosure requirements. There is no financial data, earnings information, or report content. It is a procedural and governance-related document concerning shareholder meeting voting processes. It is not an announcement of voting results, nor a proxy solicitation, but rather a governance-related procedural guideline. Therefore, the document best fits the category of Governance Information (CGR). The document length is 4444 characters, which is relatively short but contains substantive procedural content, not just an announcement or notice.
2025-09-10 Chinese
安杰思内幕信息知情人登记管理制度
Governance Information Classification · 95% confidence The document is titled as an "Insider Information Registration Management System" for a company, detailing rules and procedures for managing insider information, confidentiality obligations, insider trading restrictions, and the registration and reporting of insider information holders. It references relevant laws and regulatory requirements but does not contain financial statements, earnings data, or any report of financial performance. It is a governance-related document outlining internal policies and compliance procedures related to insider information management. Therefore, it fits best under Governance Information (CGR). The document length is sufficient and it is not a mere announcement or certification, so it is not RPA or RNS.
2025-09-10 Chinese
安杰思防止大股东及关联方占用公司资金管理制度
Governance Information Classification · 95% confidence The document is a detailed internal management system titled '防止大股东及关联方占用公司资金管理制度' (Management System to Prevent Major Shareholders and Related Parties from Occupying Company Funds) issued by 杭州安杰思医学科技股份有限公司. It outlines principles, responsibilities, and procedures to prevent misuse of company funds by major shareholders and related parties. The content is regulatory and governance-related, focusing on internal controls, responsibilities of board and management, and compliance with laws and stock exchange rules. There is no indication that this is an annual report, audit report, earnings release, or any financial statement. It is not a brief announcement or a presentation but a governance policy document. Therefore, the most appropriate classification is Governance Information (CGR). The document length (3640 characters) and content confirm it is a substantive governance report rather than a short announcement or certification.
2025-09-10 Chinese
安杰思关于作废2023年限制性股票激励计划部分已授予但尚未归属的限制性股票的公告
Board/Management Information Classification · 95% confidence The document is an announcement from a company regarding the cancellation of part of its 2023 restricted stock incentive plan, specifically the portion of restricted stocks that were granted but not yet vested. It details the decision-making process, approvals by the board and supervisory committee, legal opinions, and the impact of the cancellation on the company. The document is a formal announcement about changes in the company's stock incentive plan rather than a full report or financial statement. It does not contain financial statements or detailed financial analysis but focuses on governance and management decisions related to stock incentives. This fits best under the category of Board/Management Information (MANG), which covers announcements of changes in company management or board-related decisions, including stock incentive plans and related approvals.
2025-09-10 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.